Athera raises SEK 18.1M from exisiting investors

On March 23, 2017, the Board of Directors of Athera Biotechnologies AB, with the authorization of the Extraordinary General Meeting of 19 January 2017, decided to issue a new share issue by increasing the Company's share capital, with preferential rights for shareholders registered in the share register. The rights issue results in the Company being paid approximately SEK 18.1 million before and after deduction of issue costs (SEK 0). The shares were subscribed by existing shareholders and key personnel in the team.